lobbying_activities: 2191354
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2191354 | 502ae626-a527-4eae-9ebc-b8ae51a78244 | 3A | MYRIAD GENETICS, INC. | 401104995 | MYRIAD GENETICS, INC. | 2018 | third_quarter | MED | Regulation of laboratory developed tests - discussion draft in House - The Diagnostic Accuracy and Innovation Act (DAIA); no HR # | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2018-10-18T13:12:10.003000-04:00 |